CYABRA, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
“June 9, 2026, Cyabra, Inc. (the “Company”) received notices from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that the Company was no longer in compliance with (i) Nasdaq Listing Rule 5450(b)(2)(C) due to its failure to maintain a minimum Market Value of Publicly Held Shares (MVPHS) of $15,000,000 (the “MVPHS Rule”), based upon a review of the Company’s MVPHS for the 30 consecutive business days ended June 8, 2026 and (ii) Nasdaq Listing Rule 5450(a)(1) due to the failure of its common stock to maintain a minimum bid price of $1.00 per share for the 30”
Listing & Compliance Notices
CYABRA, INC. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).
“June 9, 2026, Cyabra, Inc. (the “Company”) received notices from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC indicating that the Company was no longer in compliance with (i) Nasdaq Listing Rule 5450(b)(2)(C) due to its failure to maintain a minimum Market Value of Publicly Held Shares (MVPHS) of $15,000,000 (the “MVPHS Rule”), based upon a review of the Company’s MVPHS for the 30 consecutive business days ended June 8, 2026 and (ii) Nasdaq Listing Rule 5450(a)(1) due to the failure of its common stock to maintain a minimum bid price of $1.00 per share for the 30”
Equity Issuances
CYABRA, INC. issued preferred stock.
“on March 26, 2026, the Company filed the Series A Convertible Preferred Stock Certificate of Designation (as corrected by the Certificate of Correction (the “Certificate of Correction”) filed with the State of Delaware on March 27, 2026, the “Series A Certificate of Designation”)”
Equity Issuances
CYABRA, INC. issued common stock to LifeSci and Ladenburg.
“The issuance of the LifeSci Advisor Shares and the Ladenburg Advisor Shares in connection with the financial advisory and investment banking services provided by LifeSci and Ladenburg”
Equity Issuances
CYABRA, INC. issued preferred stock to the Sponsor.
“shares of Holdings Series B Preferred Stock and Holdings Series C Preferred Stock issued to the Sponsor pursuant to the Sponsor Note”
Equity Issuances
CYABRA, INC. issued preferred stock to PIPE Investors.
“shares of Holdings Series B Preferred Stock issued to the PIPE Investors in the PIPE Investments”
Debt Financings
CYABRA, INC. incurred loan of $450,000 with Alpha Capital Anstalt at 10% per annum maturing upon the earlier of (i) the date of the consummation of the Business Combination or (ii) March 19, 2026.
“On March 9, 2026, Alpha provided Cyabra with a loan in the aggregate amount of $450,000 in the form of a promissory note (the “March 2026 Promissory Note”). The March 2026 Promissory Note becomes due upon the earlier of (i) the date of the consummation of the Business Combination or (ii) March 19, 2026. Cyabra shall prepay the March 2026 Promissory Note with 50% of all gross revenue of Cyabra or proceeds of any financing net of any reseller or broker fees, within ten (10) business days of receipt of any such funds, until the March 2026 Promissory Note has been repaid in full. Immediately prior to the Closing of the Business Combination, the accrued interest on the March 2026 Promissory Note amounted to $2,000. The March 2026 Promissory Note accrued interest at a rate of 10% per annum. Upon the Closing of the Business Combination, the March 2026 Promissory Note remained outstanding.”
Debt Financings
CYABRA, INC. incurred loan of $1,000,000 with Alpha Capital Anstalt at 10% per annum maturing upon the earlier of (i) the date of the consummation of the Business Combination or (ii) February 18, 2026.
“On February 5, 2026, Alpha provided Cyabra with a loan in the aggregate amount of $1.0 million in the form of a promissory note (the “February 2026 Promissory Note”). The February 2026 Promissory Note becomes due upon the earlier of (i) the date of the consummation of the Business Combination or (ii) February 18, 2026. Cyabra shall prepay the February 2026 Promissory Note with 50% of all gross revenue of Cyabra or proceeds of any financing net of any reseller or broker fees, within ten (10) business days of receipt of any such funds, until the February 2026 Promissory Note has been repaid in full. Immediately prior to the Closing of the Business Combination, the accrued interest on the February 2026 Promissory Note amounted to $14,000. The February 2026 Promissory Note accrued interest at a rate of 10% per annum. Upon the Closing of the Business Combination, the February 2026 Promissory Note remained outstanding.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.